Eradication of parvovirus B19 infection after renal transplantation requires reduction of immunosuppression and high-dose immunoglobulin therapy.
Liefeldt
Lutz
L
Department of Nephrology, Charité, Humboldt-University Berlin, Germany. lutz.liefeldt@charite.de
Buhl
Martin
M
Schweickert
Britta
B
Engelmann
Elisabeth
E
Sezer
Orhan
O
Laschinski
Peter
P
Preuschof
Lothar
L
Neumayer
Hans-H
HH
D000328:Adult; D000740:Anemia / Q000821:virology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage*; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D016030:Kidney Transplantation; D008297:Male; D010322:Parvoviridae Infections / Q000150:complications / Q000209:etiology*; D016732:Parvovirus B19, Human
D007136:Immunoglobulins